Volker Berl

Volker G.
Berl is the founder of Venock, Inc., founded in 2019, serving as Director since 2019.
Dr. Berl is the founder of New Age Ventures LLC, founded in 2009, serving as CEO & Managing Partner since 2009.
Dr. Berl is also the founder of Mycell Technologies LLC.
Dr. Berl currently serves as Independent Director at Standard Lithium Ltd. since 2021, Independent Director at Cohen Circle Acquisition Corp.
II since 2025, Director at FEMSelect Ltd. since 2022, Executive Director at Artract Medical, Inc. since 2021, and is a Member of Beta Gamma Sigma, Inc., Gesellschaft Deutscher Chemiker eV, and Tönissteiner Kreis ev.
Former positions include Independent Director at Gaussin SA from 2007 to 2024, Director at OrthogenRx, Inc. from 2015 to 2022, Director at Leaderlease, Director at MetaSoul, Inc., Independent Director at FTAC Zeus Acquisition Corp., Director at Navigate GmbH from 2007 to 2010, Vice President-Equity Research Pharmaceuticals at Deutsche Bank AG in 2006, Manager-Global New Business Development at BASF SE from 2005 to 2006, Chief Technology Officer at Zymes LLC from 2008 to 2009, and General Manager-Finance at SyncEvolution SARL from 2006 to 2016.
Education includes an MBA from Concordia University in 2004, graduate studies at Swiss Federal Institute of Technology, a doctorate from the University of Strasbourg in 2000, undergraduate degree from Karlsruher Institut für Technologie in 1993, graduate studies at École Nationale Supérieure de Chimie de Paris, and a graduate degree from Ecole Européenne De Chimie, Polymères Et Matériaux in 1996.